Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Assessment of Shave Removal Without Further Excision in the Treatment of Spitz Nevi: A Retrospective Study of 58 Cases.

Nawrocki S, Mikhail N, Ghotb S, Maghari A.

J Cutan Med Surg. 2019 Dec 6:1203475419892956. doi: 10.1177/1203475419892956. [Epub ahead of print]

PMID:
31808712
2.

An Educate, test and treat model towards elimination of hepatitis C infection in Egypt: Feasibility and effectiveness in 73 villages.

Shiha G, Soliman R, Mikhail NNH, Easterbrook P.

J Hepatol. 2019 Nov 14. pii: S0168-8278(19)30672-5. doi: 10.1016/j.jhep.2019.11.004. [Epub ahead of print]

PMID:
31734097
3.

Hepatitis C incidence 3 years after implementation of an educate, test, and treat programme in an Egyptian village.

Shiha G, Soliman R, Mikhail NNH, Easterbrook P.

Lancet Gastroenterol Hepatol. 2019 Jan;4(1):13-14. doi: 10.1016/S2468-1253(18)30336-4. Epub 2018 Dec 6. No abstract available.

PMID:
30527578
4.

Chronic Hepatitis C Patients with Obesity: Do we Need two Operators for Accurate Evaluation of Liver Stiffness?

Shiha GE, El-Etreby S, Bahgat M, Hamed M, El Sherbini M, Ghoneem EA, Zalata K, Soliman RE, El Basiouny MA, Mikhail NN.

Ann Hepatol. 2018 Aug 24;17(5):795-801. doi: 10.5604/01.3001.0012.3138.

5.

An educate, test, and treat programme towards elimination of hepatitis C infection in Egypt: a community-based demonstration project.

Shiha G, Metwally AM, Soliman R, Elbasiony M, Mikhail NNH, Easterbrook P.

Lancet Gastroenterol Hepatol. 2018 Nov;3(11):778-789. doi: 10.1016/S2468-1253(18)30139-0. Epub 2018 Jul 18. Erratum in: Lancet Gastroenterol Hepatol. 2018 Nov;3(11):e6.

PMID:
30030068
6.

High spontaneous clearance of symptomatic iatrogenic acute hepatitis C genotype 4 infection.

Hashem M, Zaghla H, Zakaria Z, Allam WR, Sameea EA, Mikhail NN, Sobhy M, Galal IF, Mokhtar Y, Hamdy S, Galal G, Abdelwahab SF, Waked I.

J Med Virol. 2018 Dec;90(12):1841-1847. doi: 10.1002/jmv.25270. Epub 2018 Aug 13.

PMID:
30011346
7.

Author Correction: Strong associations between chromosomal aberrations in blood lymphocytes and the risk of urothelial and squamous cell carcinoma of the bladder.

Wang H, Wang Y, Kota KK, Sun B, Kallakury B, Mikhail NN, Sayed D, Mokhtar A, Maximous D, Yassin EH, Sun SX, Chen X, Loffredo CA, Zheng YL.

Sci Rep. 2018 May 22;8(1):8183. doi: 10.1038/s41598-018-26488-0.

8.

Cardiovascular Effects of Liraglutide.

Mikhail N.

Curr Hypertens Rev. 2019;15(1):64-69. doi: 10.2174/1573402114666180507152620. Review.

PMID:
29737256
9.

Sofosbuvir plus Daclatasvir with or without ribavirin for treatment of chronic HCV genotype 4 patients: real-life experience.

Shiha G, Soliman R, ElBasiony M, Hassan AA, Mikhail NNH.

Hepatol Int. 2018 Jul;12(4):339-347. doi: 10.1007/s12072-018-9861-2. Epub 2018 Apr 16.

PMID:
29663115
10.

Strong associations between chromosomal aberrations in blood lymphocytes and the risk of urothelial and squamous cell carcinoma of the bladder.

Wang H, Wang Y, Kota KK, Sun B, Kallakury B, Mikhail NN, Sayed D, Mokhtar A, Maximous D, Yassin EH, Sun SX, Chen X, Loffredo CA, Zheng YL.

Sci Rep. 2017 Oct 18;7(1):13493. doi: 10.1038/s41598-017-13976-y. Erratum in: Sci Rep. 2018 May 22;8(1):8183.

11.

Effects of Evolocumab on Cardiovascular Events.

Mikhail N.

Curr Cardiol Rev. 2017;13(4):319-324. doi: 10.2174/1573403X13666170918165713. Review.

12.

A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-significant and significant fibrosis in patients with chronic hepatitis C.

Shiha G, Seif S, Eldesoky A, Elbasiony M, Soliman R, Metwally A, Zalata K, Mikhail N.

Hepatol Int. 2017 May;11(3):286-291. doi: 10.1007/s12072-017-9796-z. Epub 2017 Apr 19.

PMID:
28425016
13.

Retrospective analysis of biopsied oral and maxillofacial lesions in South-Western Saudi Arabia.

Saleh SM, Idris AM, Vani NV, Tubaigy FM, Alharbi FA, Sharwani AA, Mikhail NT, Warnakulasuriya S.

Saudi Med J. 2017 Apr;38(4):405-412. doi: 10.15537/smj.2017.4.18760.

14.

Place of technosphere inhaled insulin in treatment of diabetes.

Mikhail N.

World J Diabetes. 2016 Dec 15;7(20):599-604. doi: 10.4239/wjd.v7.i20.599. Review.

15.

Safety of Technosphere Inhaled Insulin.

Mikhail N.

Curr Drug Saf. 2017;12(1):27-31. doi: 10.2174/1574886311666160829144240. Review.

PMID:
27572546
16.

Excess mortality rate associated with hepatitis C virus infection: A community-based cohort study in rural Egypt.

Mostafa A, Shimakawa Y, Medhat A, Mikhail NN, Chesnais CB, Arafa N, Bakr I, El Hoseiny M, El-Daly M, Esmat G, Abdel-Hamid M, Mohamed MK, Fontanet A.

J Hepatol. 2016 Jun;64(6):1240-6. doi: 10.1016/j.jhep.2016.02.033. Epub 2016 Feb 26.

PMID:
26921686
17.

Strong association between long and heterogeneous telomere length in blood lymphocytes and bladder cancer risk in Egyptian.

Wang H, Wang Y, Kota KK, Kallakury B, Mikhail NN, Sayed D, Mokhtar A, Maximous D, Yassin EH, Gouda I, Sobitan A, Sun B, Loffredo CA, Zheng YL.

Carcinogenesis. 2015 Nov;36(11):1284-90. doi: 10.1093/carcin/bgv121. Epub 2015 Sep 5.

18.

Remogliflozin etabonate: a novel SGLT2 inhibitor for treatment of diabetes mellitus.

Mikhail N.

Expert Opin Investig Drugs. 2015;24(10):1381-7. doi: 10.1517/13543784.2015.1061501. Epub 2015 Aug 14. Review.

PMID:
26288025
19.

Remogliflozin etabonate : a novel SGLT2 inhibitor for treatment of diabetes mellitus.

Mikhail N.

Expert Opin Investig Drugs. 2015 Aug 14:1-7. [Epub ahead of print]

PMID:
26271274
20.

Differential distribution of IL28B.rs12979860 single-nucleotide polymorphism among Egyptian healthcare workers with and without a hepatitis C virus-specific cellular immune response.

Abdelwahab SF, Zakaria Z, Sobhy M, Hamdy S, Mahmoud MA, Mikhail N, Allam WR, Rewisha E, Waked I.

Arch Virol. 2015 Jul;160(7):1741-50. doi: 10.1007/s00705-015-2446-7. Epub 2015 May 15.

PMID:
25971683
21.

Use of sodium-glucose cotransporter type 2 inhibitors in older adults with type 2 diabetes mellitus.

Mikhail N.

South Med J. 2015 Feb;108(2):91-6. doi: 10.14423/SMJ.0000000000000235. Review.

PMID:
25688893
22.

Place of sodium-glucose co-transporter type 2 inhibitors for treatment of type 2 diabetes.

Mikhail N.

World J Diabetes. 2014 Dec 15;5(6):854-9. doi: 10.4239/wjd.v5.i6.854. Review.

23.

Cancer incidence in egypt: results of the national population-based cancer registry program.

Ibrahim AS, Khaled HM, Mikhail NN, Baraka H, Kamel H.

J Cancer Epidemiol. 2014;2014:437971. doi: 10.1155/2014/437971. Epub 2014 Sep 21.

24.

Allogenic hepatocyte transplantation in immunomodulated Lewis rats with acute liver insufficiency following hepatectomy.

Moharib MN, Waldemar, Olszewski L, Mikhail NE, Nossier MM, Atta SA, Saber MA.

J Egypt Soc Parasitol. 2014 Apr;44(1):221-8.

PMID:
24961028
25.

Endoscopically identified pseudomelanosis duodeni: striking yet harmless.

Siderits R, Hazra A, Mikhail N, Chiaffarano J, Lou W, Fyfe B.

Gastrointest Endosc. 2014 Sep;80(3):508-10. doi: 10.1016/j.gie.2014.04.036. Epub 2014 Jun 11. No abstract available.

PMID:
24929481
26.

Schistosomiasis does not affect the outcome of HCV infection in genotype 4-infected patients.

Allam WR, Barakat A, Zakaria Z, Galal G, Abdel-Ghafar TS, El-Tabbakh M, Mikhail N, Waked I, Abdelwahab SF.

Am J Trop Med Hyg. 2014 May;90(5):823-9. doi: 10.4269/ajtmh.13-0703. Epub 2014 Mar 10.

27.

Who would really benefit from DPP-4 inhibitors?

Mikhail N.

Endocrine. 2014 May;46(1):6-7. doi: 10.1007/s12020-014-0189-y. Epub 2014 Feb 8. No abstract available.

PMID:
24510631
28.

Effects of incretin-based therapy in patients with heart failure and myocardial infarction.

Mikhail N.

Endocrine. 2014 Sep;47(1):21-8. doi: 10.1007/s12020-014-0175-4. Epub 2014 Feb 4. Review.

PMID:
24493030
29.

Safety of canagliflozin in patients with type 2 diabetes.

Mikhail N.

Curr Drug Saf. 2014;9(2):127-32.

PMID:
24446889
30.

Pesticides, gene polymorphisms, and bladder cancer among Egyptian agricultural workers.

Amr S, Dawson R, Saleh DA, Magder LS, St George DM, El-Daly M, Squibb K, Mikhail NN, Abdel-Hamid M, Khaled H, Loffredo CA.

Arch Environ Occup Health. 2015;70(1):19-26. doi: 10.1080/19338244.2013.853646.

31.

Genetic polymorphisms in NQO1 and SOD2: interactions with smoking, schistosoma infection, and bladder cancer risk in Egypt.

Goerlitz D, Amr S, Dash C, Saleh DA, El Daly M, Abdel-Hamid M, El Kafrawy S, Hifnawy T, Ezzat S, Abdel-Aziz MA, Khaled H, Zheng YL, Mikhail N, Loffredo CA.

Urol Oncol. 2014 Jan;32(1):47.e15-20. doi: 10.1016/j.urolonc.2013.06.016. Epub 2013 Sep 10.

32.

Agricultural workers and urinary bladder cancer risk in Egypt.

Amr S, Dawson R, Saleh DA, Magder LS, Mikhail NN, St George DM, Squibb K, Khaled H, Loffredo CA.

Arch Environ Occup Health. 2014;69(1):3-10. doi: 10.1080/19338244.2012.719556.

33.

Management of hyperglycemia in hospitalized noncritical patients.

Mikhail N.

South Med J. 2013 Mar;106(3):238-46. doi: 10.1097/SMJ.0b013e318287febe.

PMID:
23462495
34.

E-learning in medical education in resource constrained low- and middle-income countries.

Frehywot S, Vovides Y, Talib Z, Mikhail N, Ross H, Wohltjen H, Bedada S, Korhumel K, Koumare AK, Scott J.

Hum Resour Health. 2013 Feb 4;11:4. doi: 10.1186/1478-4491-11-4.

35.

Incidence of hepatitis C virus infection among Egyptian healthcare workers at high risk of infection.

Abdelwahab SF, Hashem M, Galal I, Sobhy M, Abdel-Ghaffar TS, Galal G, Mikhail N, El-Kamary SS, Waked I, Strickland GT.

J Clin Virol. 2013 May;57(1):24-8. doi: 10.1016/j.jcv.2013.01.005. Epub 2013 Jan 29.

PMID:
23375237
36.

Biological markers and response to neoadjuvant taxane-based chemotherapy in patients with locally advanced breast cancer.

El-Sayed MI, Maximous DW, Zakhary MM, Mikhail NN.

ISRN Oncol. 2012;2012:245891. doi: 10.5402/2012/245891. Epub 2012 Dec 17.

37.

Protective role of humoral immune responses during an outbreak of hepatitis E in Egypt.

Shata MT, Daef EA, Zaki ME, Abdelwahab SF, Marzuuk NM, Sobhy M, Rafaat M, Abdelbaki L, Nafeh MA, Hashem M, El-Kamary SS, Shardell MD, Mikhail NN, Strickland GT, Sherman KE.

Trans R Soc Trop Med Hyg. 2012 Oct;106(10):613-8. doi: 10.1016/j.trstmh.2012.07.004. Epub 2012 Aug 28.

PMID:
22938992
38.

Use of dipeptidyl peptidase-4 inhibitors for the treatment of patients with type 2 diabetes mellitus and chronic kidney disease.

Mikhail N.

Postgrad Med. 2012 Jul;124(4):138-44. doi: 10.3810/pgm.2012.07.2575. Review.

PMID:
22913902
39.

Renal pelviceal keratinizing squamous metaplasia with sparing of pyramidal zones.

Siderits RH, Fingerman J, Hazra A, Rimmer C, Colaco M, Mikhail N, Ardeleanu C, Mazari PM.

Case Rep Urol. 2012;2012:242780. doi: 10.1155/2012/242780. Epub 2012 Jan 26.

40.

Safety of dipeptidyl peptidase 4 inhibitors for treatment of type 2 diabetes.

Mikhail N.

Curr Drug Saf. 2011 Nov 1;6(5):304-9. Review.

PMID:
22424537
41.

Risk factors for hepatitis C virus infection among Egyptian healthcare workers in a national liver diseases referral centre.

Abdelwahab S, Rewisha E, Hashem M, Sobhy M, Galal I, Allam WR, Mikhail N, Galal G, El-Tabbakh M, El-Kamary SS, Waked I, Strickland GT.

Trans R Soc Trop Med Hyg. 2012 Feb;106(2):98-103. doi: 10.1016/j.trstmh.2011.10.003. Epub 2011 Dec 22.

PMID:
22197011
42.

Urinary bladder cancer risk factors in Egypt: a multicenter case-control study.

Zheng YL, Amr S, Saleh DA, Dash C, Ezzat S, Mikhail NN, Gouda I, Loay I, Hifnawy T, Abdel-Hamid M, Khaled H, Wolpert B, Abdel-Aziz MA, Loffredo CA.

Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):537-46. doi: 10.1158/1055-9965.EPI-11-0589. Epub 2011 Dec 6.

43.

Genetic polymorphism in IL28B is associated with spontaneous clearance of hepatitis C virus genotype 4 infection in an Egyptian cohort.

Kurbanov F, Abdel-Hamid M, Latanich R, Astemborski J, Mohamed M, Mikhail NM, El-Daly M, El-Kafrawy S, Thomas DL, Thio CL.

J Infect Dis. 2011 Nov;204(9):1391-4. doi: 10.1093/infdis/jir536. Epub 2011 Sep 20.

44.

Quick-release bromocriptine for treatment of type 2 diabetes.

Mikhail N.

Curr Drug Deliv. 2011 Sep;8(5):511-6.

PMID:
21696353
45.

GSTM1, GSTT1 null variants, and GPX1 single nucleotide polymorphism are not associated with bladder cancer risk in Egypt.

Goerlitz D, El Daly M, Abdel-Hamid M, Saleh DA, Goldman L, El Kafrawy S, Hifnawy T, Ezzat S, Abdel-Aziz MA, Zaghloul MS, Ali SR, Khaled H, Amr S, Zheng YL, Mikhail N, Loffredo C.

Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1552-4. doi: 10.1158/1055-9965.EPI-10-1306. Epub 2011 May 17.

46.

Associations differ by sex for catechol-O-methyltransferase genotypes and bladder cancer risk in South Egypt.

Wolpert BJ, Amr S, Saleh DA, Ezzat S, Gouda I, Loay I, Hifnawy T, Abdel-Hamid M, Mikhail NN, Zhan M, Zheng YL, Squibb K, Abdel-Aziz MA, Zaghloul MS, Khaled H, Loffredo CA.

Urol Oncol. 2012 Nov-Dec;30(6):841-7. doi: 10.1016/j.urolonc.2010.09.007. Epub 2011 Mar 11.

47.

Clinical significance of vitamin D deficiency in primary hyperparathyroidism, and safety of vitamin D therapy.

Mikhail N.

South Med J. 2011 Jan;104(1):29-33. doi: 10.1097/SMJ.0b013e3181fcd772. Review.

PMID:
21079532
48.

Estrogen exposure and bladder cancer risk in Egyptian women.

Wolpert BJ, Amr S, Ezzat S, Saleh D, Gouda I, Loay I, Hifnawy T, Mikhail NN, Abdel-Hamid M, Zhan M, Zheng YL, Squibb K, Abdel-Aziz MA, Zaghloul M, Khaled H, Loffredo CA.

Maturitas. 2010 Dec;67(4):353-7. doi: 10.1016/j.maturitas.2010.07.014. Epub 2010 Sep 1.

49.

Feasibility of breast conservation after neoadjuvant taxene based chemotherapy in locally advanced breast cancer: a Prospective Phase I trial.

El-Sayed MI, Maximous DW, Aboziada MA, Abdel-Wanis ME, Mikhail NN.

Ann Surg Innov Res. 2010 Aug 31;4:5. doi: 10.1186/1750-1164-4-5.

50.

Collection, storage and use of blood samples for future research: views of Egyptian patients expressed in a cross-sectional survey.

Abou-Zeid A, Silverman H, Shehata M, Shams M, Elshabrawy M, Hifnawy T, Rahman SA, Galal B, Sleem H, Mikhail N, Moharram N.

J Med Ethics. 2010 Sep;36(9):539-47. doi: 10.1136/jme.2009.033100. Epub 2010 Jul 26.

PMID:
20663757

Supplemental Content

Loading ...
Support Center